The estimated Net Worth of James P Mackin is at least $18.2 Million dollars as of 30 April 2021. Mr. Mackin owns over 45,734 units of Artivion Inc stock worth over $5,965,608 and over the last 10 years he sold CRY stock worth over $5,738,681. In addition, he makes $6,453,540 as Chairman of the Board, President, Chief Executive Officer und Director at Artivion Inc.
James has made over 8 trades of the Artivion Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 45,734 units of CRY stock worth $465,572 on 30 April 2021.
The largest trade he's ever made was exercising 150,000 units of Artivion Inc stock on 13 August 2018 worth over $1,536,000. On average, James trades about 12,178 units every 52 days since 2014. As of 30 April 2021 he still owns at least 333,647 units of Artivion Inc stock.
You can see the complete history of Mr. Mackin stock trades at the bottom of the page.
James Patrick (Pat) Mackin Chairman of the Board, President, Chief Executive Officer of the Company. He as named President and Chief Executive Officer of CryoLife in September 2014. He was appointed to the CryoLife Board of Directors in October 2014, and he was appointed Chairman of the Board of Directors in April 2015. Mr. Mackin has more than 25 years of experience in the medical device industry. Prior to joining CryoLife, Mr. Mackin served as President of Cardiac Rhythm Disease Management, the then largest operating division of Medtronic plc (NYSE: MDT) (“Medtronic”), from August 2007 to August 2014. At Medtronic, he previously held the positions of Vice President, Vascular, Western Europe and Vice President and General Manager, Endovascular Business Unit. Prior to joining Medtronic in 2002, Mr. Mackin worked for six years at Genzyme, Inc., serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products division. Before joining Genzyme, Inc., Mr. Mackin spent four years at Deknatel/Snowden-Pencer, Inc. in various roles and three years as a First Lieutenant in the U.S. Army. Mr. Mackin has served as a director of Opsens, Inc. (TSXV: OPS and OTCQX: OPSSF), a fiber optic sensors manufacturer, since 2016. Mr. Mackin has served as a director of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics, since July 2018. Mr. Mackin received an MBA from the Kellogg Graduate School of Management at Northwestern University and is a graduate of the U.S. Military Academy at West Point.
As the Chairman of the Board, President, Chief Executive Officer und Director of Artivion Inc, the total compensation of James Mackin at Artivion Inc is $6,453,540. There are no executives at Artivion Inc getting paid more.
James Mackin is 53, he's been the Chairman of the Board, President, Chief Executive Officer und Director of Artivion Inc since 2015. There are 15 older and 6 younger executives at Artivion Inc. The oldest executive at Artivion Inc is Ronald McCall, 83, who is the Presiding Independent Director.
James's mailing address filed with the SEC is 1023, Cherry Road, The Village, Memphis, Shelby County, Tennessee, 38117, United States of America.
Over the last 21 years, insiders at Artivion Inc have traded over $18,346,910 worth of Artivion Inc stock and bought 91,700 units worth $1,086,548 . The most active insiders traders include Steven G Anderson, Thomas F Ackerman und James P Mackin. On average, Artivion Inc executives and independent directors trade stock every 26 days with the average trade being worth of $211,842. The most recent stock trade was executed by Amy Horton on 8 December 2021, trading 2,500 units of CRY stock currently worth $46,425.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.
Artivion Inc executives and other stock owners filed with the SEC include: